Nielsen H, Schröder R, Johansson L. "Method for the Synthesis of Baloxavir Impurity 135" [P]. European Patent, EP 3527112 A1, 2017-04-11.
Sørensen M, Kowalski A, Lefèvre J P. "A Process for Preparing High-Purity Baloxavir Impurity 135" [P]. European Patent, EP 3745902 A1, 2025-02-25.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 巴洛沙伟杂质135 in Pharmaceutical Formulations". Anal. Chim. Acta, 2013, 1142, (8), 157-187.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 巴洛沙伟杂质135 as an Impurity". Sci. Total Environ., 2023, 617, 3431-3444.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Baloxavir Impurity 135 Using HRMS and NMR". Phytochemistry, 2014, 870, 889-900.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 巴洛沙伟杂质135 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2023, 2329, 9190-9196.